8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2016 / Narrative review
This review argues that dietary cholesterol should be limited to <200 mg/day in individuals at risk of vascular disease. Egg yolk consumption raises fasting LDL cholesterol by ~10%, and high fat/high cholesterol meals induce postprandial oxidative stress, endothelial dysfunction, and arterial inflammation for ~4 hours. Furthermore, egg yolk phosphatidylcholine is metabolized by the gut microbiome into TMAO; top-quartile TMAO levels after a test dose of two egg yolks were linked to a 2.5-fold increase in 3-year risk of stroke, death, or myocardial infarction in coronary angiography patients.
David Spence J J Transl Int Med, 2016. PMID 28191513
2016 / Narrative review
This review discusses the role of whole food, plant-based nutrition (WFPBN) in addressing cardiovascular disease (CVD). The author notes that CVD is virtually nonexistent in multiple WFPBN cultures and that plant-based nutrition's capacity to prevent and halt CVD has been shown across epidemiological data, wartime deprivation, cohort studies, and prospective trials. In addition, basic research indicates omnivores harbor gut bacteria capable of converting animal food into vessel-injuring trimethylamine oxide (TMAO), whereas individuals consuming only plants lack bacteria that produce TMAO. The article questions why cardiovascular medicine continues to prioritize palliative treatments despite evidence supporting plant nutrition.
Esselstyn CB Am J Lifestyle Med, 2016. PMID 30202287
2015 / Narrative review
This review critically discusses experimental studies and clinical trials investigating the atheroprotective effects of dietary (poly)phenols. Epidemiological observations indicate that intake of (poly)phenols from sources including nuts, coffee, cocoa, grapes, and berries may protect against atherosclerosis. While previously attributed to antioxidant or anti-inflammatory activities, emerging data suggest these compounds can modulate cellular lipid metabolism to mitigate atherosclerotic plaque formation.
Zanotti I, Dall'Asta M, Mena P, et al. Food Funct, 2015. PMID 25367393
2015 / Narrative review
This review takes a devil's advocate position to discuss subgroups of obese individuals who may not be adversely affected by their weight, or who may even benefit from higher adiposity. It examines situations where weight loss per se may not be the most appropriate recommendation. Specifically, it addresses adults with established cardiovascular disease, type 2 diabetes, weight cyclers, metabolically healthy obese adults, youth, older adults, and highly fit obese individuals.
Brown RE, Kuk JL Obes Rev, 2015. PMID 25410935
2015 / Narrative review
This review explores the mechanistic evidence supporting a plant-based diet for coronary artery disease (CAD) prevention. It highlights that dietary plant polyphenols confer protective, antioxidant effects on vascular endothelial cells, while high meat and fat intake promote endothelial dysfunction. Ingestion of red meat produces L-carnitine metabolites such as trimethylamine-N-oxide (TMAO), which is associated with atherosclerosis via gut microbiome metabolism in omnivores but not vegetarians.
Tuso P, Stoll SR, Li WW Perm J, 2015. PMID 25431999
2015 / Narrative review
This review evaluates the metabolic effects and mechanism of action of resveratrol, a polyphenol found in plant-based foods such as red wine. Resveratrol has been reported to have diverse healthful effects, including improving mitochondrial function and protecting against obesity, type-2 diabetes, cardiovascular dysfunction, and cancer cell growth. However, clinical trials investigating its metabolic effects have produced mixed results, leaving several controversies unresolved.
Bitterman JL, Chung JH Cell Mol Life Sci, 2015. PMID 25548801
2015 / Systematic review
A systematic review searched literature from January 1980 through May 2014, identifying 43 relevant reports out of 2,097 publications on the adverse health effects of energy drinks. Energy drink consumption was noted as a health issue primarily in adolescent and young adult males and was linked to increased substance abuse and risk-taking behaviors. The most common adverse events affected the cardiovascular and neurological systems, believed to be related to caffeine and potentiating effects of other stimulants.
Shows an association, not proof of cause and effect.
Ali F, Rehman H, Babayan Z, et al. Postgrad Med, 2015. PMID 25560302
2015 / Roundtable discussion summary report
A roundtable of behavioral nutrition experts, researchers, and nutrition educators reviewed candy consumption patterns, related health outcomes, and behavioral strategies to promote moderation. Although 97% of Americans report eating candy at least once yearly, only about one-fourth of the US population aged ≥2 years consumes it on a given day, contributing a relatively small proportion of calories, added sugars, and saturated fat. Recent research cited suggests current candy consumption levels are not associated with weight gain or cardiovascular disease risk in children and adults. The panel noted that restricting access to palatable foods may have negative consequences and identified behavioral and environmental strategies as key steps to promote moderation.
Shows an association, not proof of cause and effect.
Duyff RL, Birch LL, Byrd-Bredbenner C, et al. Adv Nutr, 2015. PMID 25593156
2015 / Narrative review
Pre-clinical findings indicate that resveratrol may protect against various medical conditions and age-related complications. However, there is no consistent evidence of increased protection against metabolic disorders and other ailments when comparing animal and human studies. The review notes that most human studies examining resveratrol administration and patient outcomes have been limited by sample sizes. It evaluates advances in timing, dosage, formulation, bioavailability, toxicity, and drug interactions, as well as disease actions in cancer, diabetes, neurodegeneration, and cardiovascular disease.
Novelle MG, Wahl D, Diéguez C, et al. Ageing Res Rev, 2015. PMID 25625901
2015 / Narrative review
This review evaluates individual interventions to mitigate health risks from ambient air pollution. Exposure can be lowered by staying indoors, reducing outdoor air infiltration, utilizing air filters, limiting physical exertion outdoors, and potentially using respirators. Although research suggests possible chemopreventive options like antioxidant or antithrombotic agents, the absence of health outcome data prevents sound recommendations for primary prevention, particularly given potential adverse effects of antioxidant supplements.
Laumbach R, Meng Q, Kipen H J Thorac Dis, 2015. PMID 25694820
2015 / Narrative review
Stroke is a primary cause of death and permanent disability in the USA, prompting investigation into modifiable lifestyle factors such as diet and dietary patterns. This review explores clinical research findings linking diet to cardiovascular disease and stroke risk. The authors note that research has yet to implement dietary interventions to explore this relationship within a US sample, and they assess challenges, controversies, and future research directions.
Shows an association, not proof of cause and effect.
Boden-Albala B, Southwick L, Carman H Curr Neurol Neurosci Rep, 2015. PMID 25708674
2015 / Narrative review
This review evaluates the safety and efficacy of Moringa oleifera in human and animal studies. Five published human studies using powdered whole leaf preparations demonstrated anti-hyperglycemic (antidiabetic) and anti-dyslipidemic activities, with no adverse effects reported. Animal research also demonstrated tissue protective, antioxidant, and antihypertensive effects, among others. The authors note that product standardization remains an issue and additional human studies with standardized extracts are desirable.
Stohs SJ, Hartman MJ Phytother Res, 2015. PMID 25808883
2015 / Review
This review evaluates clinical evidence on dietary advanced glycation end products (AGEs) in chronic diseases, particularly chronic kidney disease (CKD). Clinical trials over the past decade show that an AGE-restricted diet reduces systemic AGE levels along with markers of oxidative stress and inflammation. These effects have been observed in CKD patients before and after starting dialysis, with or without coexisting diabetes. Reducing dietary AGEs through simple changes in culinary techniques is described as a feasible, safe, and easily applicable intervention.
Uribarri J, He JC Nephron, 2015. PMID 25871778
2015 / Narrative review
Since the 1980s, obesity prevalence has nearly doubled globally, with treatments including lifestyle modification, medications, and surgery. This review discusses the mechanisms and cardiometabolic implications of newly approved next-generation weight management medications. These medications demonstrate efficacy in initial weight management and long-term maintenance, while showing varying effects on diabetes and cardiovascular risks.
Wharton S, Serodio KJ Curr Cardiol Rep, 2015. PMID 25894803
2015 / Narrative review of acute and long-term feeding studies and meta-analyses
This review examines literature on mechanisms following acute protein consumption and clinical outcomes from long-term, higher-protein diets. Meta-analyses of shorter-term, tightly controlled feeding studies showed greater weight loss, fat mass loss, lean mass preservation, and reductions in triglycerides, blood pressure, and waist circumference with higher-protein diets. Acute trials confirmed modest satiety effects without affecting energy intake at the next meal, while longer-term studies yielded conflicting findings largely driven by dietary compliance. The evidence suggests diets containing 1.2 to 1.6 g protein · kg-1 · d-1 (with at least ~25-30 g/meal) provide improvements in appetite, weight management, and cardiometabolic factors.
Leidy HJ, Clifton PM, Astrup A, et al. Am J Clin Nutr, 2015. PMID 25926512
2015 / Historical review and narrative summary
An early 1980s analysis of the metabolic profiles of 930 men and women showed that an abdominal distribution of fat for a given BMI is associated with increased insulin resistance and risk of type 2 diabetes and cardiovascular disease. This correlation has since been validated across multiple studies, establishing waist circumference as a diagnostic criterion for metabolic syndrome. Visceral fat represents one of several ectopic fat depots utilized when subcutaneous adipose tissue cannot accommodate excess fat due to limited expandability.
Shows an association, not proof of cause and effect.
Smith U J Clin Invest, 2015. PMID 25932676
2015 / Narrative review
This review evaluates arguments raised against the cardiovascular safety of plant sterols and stanols. Regular intake of functional foods containing plant sterols and stanols is associated with a decrease in low density lipoprotein cholesterol of about 10% and an increase in plasma plant sterol or stanol concentrations by about a factor of 2. Although lowering low density lipoprotein cholesterol benefits cardiovascular health, safety concerns have emerged regarding the concomitant increase in circulating plant sterols.
Silbernagel G, Baumgartner I, März W J AOAC Int, 2015. PMID 25942652
2015 / Narrative review
Approximately 90% of the US population fails to consume recommended fiber levels (25 g/d for women, 38 g/d for men), averaging only 15 g/d. Fiber supplements cannot be assumed to provide the same health benefits as intact dietary fiber from whole foods, as only a minority possess the physical characteristics that drive clinical efficacy. This review focuses on four primary fiber characteristics driving efficacy—solubility, degree/rate of fermentation, viscosity, and gel formation—as well as gel-dependent small-bowel mechanisms that influence outcomes such as cholesterol lowering and glycemic control.
McRorie JW Nutr Today, 2015. PMID 25972618
2015 / Review
This narrative review examines the role of diet in the prevention and complementary clinical management of atherosclerosis. It discusses evidence and mechanisms for specific nutrients and foods, including fiber, plant sterols/stanols, niacin, taurine, olive oil, omega-3 fatty acids, antioxidants, minerals, methyl nutrients, and soy. It also highlights that intestinal microbiota dysbiosis associated with certain animal food sources can generate metabolites involved in atherosclerosis development.
Torres N, Guevara-Cruz M, Velázquez-Villegas LA, et al. Arch Med Res, 2015. PMID 26031780
2015 / Narrative review
This review summarizes findings on cocoa's effects on blood pressure and cardiovascular health, focusing on putative mechanisms. Flavanols in cocoa are reported to exert favorable effects on endothelium-derived vasodilation by stimulating nitric oxide-synthase, increasing l-arginine availability, and decreasing NO degradation. Cocoa is also associated with reduced platelet aggregation, decreased lipid oxidation, improved insulin resistance, and blood pressure reductions. The authors note that long-term trials are still needed to determine if daily cocoa reduces blood pressure chronically and improves cardiovascular clinical outcomes.
Ferri C, Desideri G, Ferri L, et al. J Agric Food Chem, 2015. PMID 26125676
2015 / Systematic review
A systematic review identified three randomized controlled clinical trials evaluating therapeutic fasting regimens on surrogate outcomes in humans, finding improvements in weight and other risk-related outcomes. In addition, two observational studies were identified in which fasting was associated with a lower prevalence of coronary artery disease or diabetes diagnosis. No randomized controlled trials of fasting for clinical outcomes were identified, and researchers concluded that substantial further human research is needed.
Horne BD, Muhlestein JB, Anderson JL Am J Clin Nutr, 2015. PMID 26135345
2015 / Narrative review
This review evaluates the benefits and risks of calcium supplementation in osteoporosis prevention. Most studies show little evidence linking calcium intake to bone density or bone loss, with re-analysis of the Auckland Calcium Study placebo group showing no relationship over 5 years across intakes of <400 to >1500 mg/day. Across meta-analyses, total fracture reductions range from 0-10% with no evidence for hip fracture prevention outside severe vitamin D deficiency, while five recent large studies failed to show fracture prevention in primary analyses. Conversely, supplements are associated with increased gastrointestinal side effects, a 17% increase in renal calculi, and a 20-40% increase in myocardial infarction risk.
Reid IR, Bristow SM, Bolland MJ J Intern Med, 2015. PMID 26174589
2015 / Narrative review
This narrative review examines dietary factors, gut microbiota, and the uremic toxin trimethylamine N-oxide (TMAO) in patients with nondialysis chronic kidney disease (CKD). Low-protein diets are recommended in this population because excess protein can harm kidney function and generate uremic toxins. TMAO, a degradation product of choline and L-carnitine derived primarily from animal protein such as red meat and eggs, is considered a proatherogenic metabolite with potential cardiovascular implications in CKD.
Moraes C, Fouque D, Amaral AC, et al. J Ren Nutr, 2015. PMID 26235933
2015 / Narrative review and metagenomic database analysis
The authors reviewed literature on gut microbiota-derived trimethylamine (TMA), a metabolite linked to atherosclerosis development, to demonstrate big data integration workflows. By translating elucidated microbial pathways for TMA production into genomic orthologs, public (meta-)genomic databases were mined and linked to metadata. Reviewing pathway abundance showed that TMA production potential is associated with symptomatic atherosclerosis and facilitated identification of previously uncharacterized TMA-producing bacteria.
Shows an association, not proof of cause and effect.
Falony G, Vieira-Silva S, Raes J Annu Rev Microbiol, 2015. PMID 26274026